Table 2 Annotation for lists of differentially expressed genes
From: Genes and pathways underlying regional and cell type changes in Alzheimer's disease
| Gene category | EASE score |
|---|---|
| Down with AD (in CA1) | |
| Synaptic transmission | 6.18E-14 |
| Cell-cell signaling | 7.88E-12 |
| CNS-specific functions | 2.99E-05 |
| Potassium channel activity | 6.46E-05 |
| Neurogenesis | 1.35E-04 |
| cAMP-mediated signaling | 5.99E-04 |
| Lipoprotein | 1.30E-03 |
| Up with AD (in CA1) | |
| Response to stress | 2.36E-05 |
| Cell-matrix adhesion | 8.79E-04 |
| MAPKKK cascade | 2.73E-03 |
| Polymorphism | 2.95E-03 |
| Hs_TGF beta signaling pathway | 5.25E-03 |
| Cell proliferation | 1.14E-02 |
| Cell death | 1.22E-02 |
| Enriched in CA3 (in control) | |
| Transport | 2.16E-11 |
| Neurogenesis | 1.85E-08 |
| CNS-specific functions | 7.37E-08 |
| Synaptic transmission | 7.27E-07 |
| Cell growth and/or maintenance | 1.28E-05 |
| Cytoskeletal protein binding | 2.80E-04 |
| Potassium transport | 3.04E-04 |
| Cholesterol biosynthesis | 4.70E-04 |
| Enriched in CA1 (in control) | |
| Signal transducer activity | 3.42E-09 |
| Response to external stimulus | 3.70E-07 |
| Metallothionein | 9.74E-06 |
| Immune response | 1.53E-05 |
| Cell-cell signaling | 1.89E-05 |
| Cell motility | 4.31E-05 |
| Homeostasis | 9.97E-05 |
| Polymorphism | 9.48E-03 |
